Seranova Bio

Natural clinical trials occur when a fraction of patients develop autoantibodies to a specific target. If patients with a specific autoantibody reactivity benefit from lessened disease severity or better outcomes, a therapeutic antibody with the same reactivity may benefit other patients.Our proprietary technology generates the most accurate and extensive collection of these "studies" ever assembled, effectively giving Seranova and our collaborators exclusive access to the results. Targets va...